SCHEMBL14780757

SCHEMBL14780757

COc1cc2nc(-c3n[nH]cc3NC(=O)C3CCC(N)CC3)[nH]c2cc1OC

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.45
PARP1 P09874 2/20 0.43
DHODH Q02127 1/20 0.42
PDPK1 O15530 2/20 0.39
FLT3 P36888 1/20 0.38
PDGFRB P09619 2/20 0.38
PDGFRA P16234 2/20 0.38
ULK1 O75385 1/20 0.38
JAK2 O60674 2/20 0.38
TYK2 P29597 1/20 0.38
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
TSHR P16473 2/20 0.37
AAK1 Q2M2I8 2/20 0.37
BRD4 O60885 1/20 0.37
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
HSD17B10 Q99714 1/20 0.36
STK17B O94768 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8302949 1.00 KDM4E (0.45) KDM4EPARP1DHODHPDPK1FLT3
SCHEMBL1645725 1.00 KDM4E (0.45) KDM4EPARP1DHODHPDPK1FLT3
SCHEMBL13373935 0.88 TSHR (0.49) KDM4EPARP1DHODHPDPK1JAK2
SCHEMBL12303905 0.84 KDM4E (0.55) KDM4ELMNAPOLBTSHRALDH1A1
SCHEMBL1646056 0.84 FLT3 (0.35) FLT3LMNAMAPT
SCHEMBL13373895 0.83 PDPK1 (0.45) KDM4EPDPK1JAK2TYK2LMNA
SCHEMBL546166 0.83 ALDH1A1 (0.41) KDM4ELMNAPOLBTSHRALDH1A1
SCHEMBL12582697 0.83 KDM4E (0.41) KDM4EDHODHULK1AAK1
SCHEMBL1644923 0.83 KDM4E (0.41) KDM4EDHODHULK1AAK1
SCHEMBL13373905 0.82 PDPK1 (0.47) KDM4EPDPK1FLT3JAK2TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399442-B2 Pharmaceutical compounds ASTEX THERAPEUTICS LIMITED (GB) 2013-03-19 US disclosed
US-8399442-B2 Pharmaceutical compounds ASTEX THERAPEUTICS LIMITED (GB) 2013-03-19 US disclosed